Stock in Curaleaf witnessed a nearly 10% rise today
In a significant development, Curaleaf (CURLF), a leading marijuana stock, saw a 10% increase in value on Thursday. This surge was primarily due to news about a potential health benefit of cannabidiol (CBD), a non-psychoactive compound found in marijuana.
The potential benefit that has sparked interest is CBD's apparent ability to improve withdrawal and relapse conditions in those suffering from alcohol use disorder (alcoholism). A clinical study, conducted by researchers at the University of California, San Diego, and partially funded by the National Institute on Alcohol Abuse and Alcoholism, revealed that CBD may be beneficial in managing symptoms of alcohol use disorder.
The study involved two cohorts of rodents that were given synthetic CBD. The results indicate that CBD may be beneficial in managing symptoms of alcohol use disorder, as the rodents that ingested CBD demonstrated milder alcohol withdrawal symptoms and had a lower risk of relapse.
This study, if further substantiated through human trials, could potentially shift the official sentiment on marijuana-derived substances, particularly CBD. The popularity of CBD has devolved into a low-profile niche product, but successful studies like this could lead to a revival of CBD.
However, it's important to note that as of now, there is no specific study mentioned in the search results about clinical trials conducted on the effects of cannabidiol on alcohol misuse addiction syndromes in humans.
The news about this potential health benefit of CBD was reported by an industry newsletter and Marijuana Moment. The report on the clinical study was published in the prestigious scientific journal, Nature.
It's essential to highlight that CBD is not a major part of Curaleaf's business. Nevertheless, the potential health benefits of CBD could have far-reaching implications for the entire marijuana industry.
This development could mark a significant step forward in the understanding and treatment of alcohol use disorder, and it underscores the potential of CBD as a therapeutic agent. As more research is conducted and the results are made public, we can expect to see continued interest in CBD and its potential applications.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Tobacco industry's suggested changes on a legislative modification are disregarded by health journalists
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
